Reversal of diabetes by βtC3 cells encapsulated in alginate beads generated by emulsion and internal gelation

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 100 B, Issue 4, 2012, Pages 1017-1028

  Hoesli, Corinne A ^a,b,d   Kiang, Roger L J ^a,b   Mocinecová, Dušana ^c   Speck, Madeleine ^b   Mošková, Daniela Jochec ^c   Donald Hague, Christine ^b   Lacík, Igor ^c   Kieffer, Timothy J ^b   Piret, James M ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c POLYMER INSTITUTE   (Slovakia)

^d UNIVERSITÉ LAVAL   (Canada)

Author keywords

cell therapy; diabetes; encapsulated cells; hydrogel; permeability

Indexed keywords

ALGINATE BEADS; BLOOD GLUCOSE LEVEL; CELL ENCAPSULATIONS; CELL SURVIVAL; CELL THERAPY; CELLULAR THERAPY; DIABETIC MICE; ENCAPSULATED CELLS; EXTRUSION PROCESS; IMMUNOPROTECTION; IN-VITRO; INTERNAL GELATION; PRODUCTION RATES; PULLULANS; TC3 CELLS; TYPE 1 DIABETES;

ALGINATE; COAGULATION; CYTOLOGY; EMULSIFICATION; GELATION; GLUCOSE; GRAFTING (CHEMICAL); HYDROGELS; MECHANICAL PERMEABILITY; MEDICAL PROBLEMS;

CELLS;

ALGINATE BEAD; ALGINIC ACID; BIOMEDICAL AND DENTAL MATERIALS; GLUCOSE; STREPTOZOCIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BETA TC3 CELL; CELL CULTURE; CELL ENCAPSULATION; CELL SURVIVAL; CELL THERAPY; CELL TRANSPLANTATION; CONTROLLED STUDY; DIABETES MELLITUS; EMULSION; GELATION; GLUCOSE BLOOD LEVEL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; VOLUMETRY;

ALGINATES; ANIMALS; BLOOD GLUCOSE; CELL SURVIVAL; CRYOELECTRON MICROSCOPY; DIABETES MELLITUS; EMULSIONS; GELS; HYDROGELS; IMMUNOSUPPRESSIVE AGENTS; INSULIN; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY, ELECTRON, SCANNING; PERMEABILITY; STRESS, MECHANICAL; TISSUE THERAPY; TRANSPLANTATION, HOMOLOGOUS; VISCOSITY;

EID: 84859564435     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.32667     Document Type: Article

References (44)

1. Lim F, Sun AM,. Microencapsulated islets as bioartificial endocrine pancreas. Science 1980; 210: 908-910.
2. Calafiore R, Basta G, Luca G, Lemmi A, Racanicchi L, Mancuso F, Montanucci MP, Brunetti P,. Standard technical procedures for microencapsulation of human islets for graft into nonimmunosuppressed patients with type 1 diabetes mellitus. Transplant Proc 2006; 38: 1156-1157.
3. Living Cell Technologies. Open-label Investigation of the Safety and Effectiveness of DIABECELL(R) in Patients With Type I Diabetes Mellitus. 2010.
4. Klein J, Stock J, Vorlop KD,. Pore-size and properties of spherical Ca-alginate biocatalysts. Eur J Appl Microbiol Biotechnol 1983; 18: 86-91.
5. Darquy S, Pueyo ME, Capron F, Reach G,. Complement activation by alginate-polylysine microcapsules used for islet transplantation. Artif Organs 1994; 18: 898-903.
6. Rokstad AM, Brekke OL, Steinkjer B, Ryan L, Kollarikova G, Strand BL, Skjak-Braek G, Lacik I, Espevik T, Mollnes TE,. Alginate microbeads are complement compatible, in contrast to polycation containing microcapsules, as revealed in a human whole blood model. Acta Biomater 2011; 7: 2566-2578.
7. Juste S, Lessard M, Henley N, Menard M, Halle JP,. Effect of poly-L-lysine coating on macrophage activation by alginate-based microcapsules: Assessment using a new in vitro method. J Biomed Mater Res A 2005; 72A: 389-398.
8. Hunt JA, Flanagan BF, McLaughlin PJ, Strickland I, Williams DF,. Effect of biomaterial surface charge on the inflammatory response: Evaluation of cellular infiltration and TNF alpha production. J Biomed Mater Res 1996; 31: 139-144.
9. de Vos P, de Haan BJ, Kamps JA, Faas MM, Kitano T,. Zeta-potentials of alginate-PLL capsules: A predictive measure for biocompatibility? J Biomed Mater Res A 2007; 80: 813-819.
10. Bunger CM, Gerlach C, Freier T, Schmitz KP, Pilz M, Werner C, Jonas L, Schareck W, Hopt UT, de Vos P,. Biocompatibility and surface structure of chemically modified immunoisolating alginate-PLL capsules. J Biomed Mater Res A 2003; 67A: 1219-1227.
11. Tam SK, Dusseault J, Polizu S, Menard M, Halle JP, Yahia L,. Physicochemical model of alginate-poly- L -lysine microcapsules defined at the micrometric/nanometric scale using ATR-FTIR, XPS, and ToF-SIMS. Biomaterials 2005; 26: 6950-6961.
12. Duvivier-Kali VF, Omer A, Parent RJ, O'Neil JJ, Weir GC,. Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane. Diabetes 2001; 50: 1698-1705.
13. Dufrane D, Goebbels RM, Saliez A, Guiot Y, Gianello P,. Six-month survival of microencapsulated pig islets and alginate biocompatibility in primates: Proof of concept. Transplantation 2006; 81: 1345-1353.
14. Tuch BE, Keogh GW, Williams LJ, Wu W, Foster JL, Vaithilingam V, Philips R,. Safety and viability of microencapsulated human islets transplanted into diabetic humans. Diabetes Care 2009; 32: 1887-1889.
15. Tuch BE, Vaithilingam V, Barbaro B, Oberholzer J,. Functional capacity of human islets after long-distance shipment and encapsulation. Pancreas 2011; 40: 247-252.
16. Smidsrod O, Skjak-Braek G,. Alginate as immobilization matrix for cells. Trends Biotechnol 1990; 8: 71-78.
17. Brissova M, Petro M, Lacik I, Powers AC, Wang T,. Evaluation of microcapsule permeability via inverse size exclusion chromatography. Anal Biochem 1996; 242: 104-111.
18. Hoesli CA, Raghuram K, Kiang RL, Mocinecova D, Hu X, Johnson JD, Lacik I, Kieffer TJ, Piret JM,. Pancreatic cell immobilization in alginate beads produced by emulsion and internal gelation. Biotechnol Bioeng 2011; 108: 424-434.
19. Poncelet D, Lencki R, Beaulieu C, Halle JP, Neufeld RJ, Fournier A,. Production of alginate beads by emulsification/internal gelation. I. Methodology. Appl Microbiol Biotechnol 1992; 38: 39-45.
20. Carpenter AE, Jones TR, Lamprecht MR, Clarke C, Kang IH, Friman O, Guertin DA, Chang JH, Lindquist RA, Moffat J, Golland P, Sabatini DM,. CellProfiler: Image analysis software for identifying and quantifying cell phenotypes. Genome Biol 2006; 7: R100.
21. Kulicke WM, Aggour YA, Elsabee MZ,. Preparation, characterization, and rheological behavior of starch-sodium trimetaphosphate hydrogels. Starch-Starke 1990; 42: 134-141.
22. Brissova M, Lacik I, Powers AC, Anilkumar AV, Wang T,. Control and measurement of permeability for design of microcapsule cell delivery system. J Biomed Mater Res 1998; 39: 61-70.
23. Davies JT,. Drop sizes of emulsions related to turbulent energy-dissipation rates. Chem Eng Sci 1985; 40: 839-842.
24. Manciu M, Ruckenstein E,. Specific ion effects via ion hydration: I. Surface tension. Adv Colloid Interface Sci 2003; 105: 63-101.
25. Smidsrod O, Haug A, Lian B,. Properties of Poly(1,4-Hexuronates) in Gel State. 1. Evaluation of a method for determination of stiffness. Acta Chem Scand 1972; 26: 71-78.
26. Cui H, Tucker-Burden C, Cauffiel SMD, Barry AK, Iwakoshi NN, Weber CJ, Safley SA,. Long-term metabolic control of autoimmune diabetes in spontaneously diabetic nonobese diabetic mice by nonvascularized microencapsulated adult porcine islets. Transplantation 2009; 88: 160-169.
27. Prusse U, Bilancetti L, Bucko M, Bugarski B, Bukowski J, Gemeiner P, Lewinska D, Manojlovic V, Massart B, Nastruzzi C, Nedovic V, Poncelet D, Siebenhaar S, Tobler L, Tosi A, Vikartovska A, Vorlop KD,. Comparison of different technologies for alginate beads production. Chem Papers 2008; 62: 364-374.
28. Brandenberger H, Widmer F,. A new multinozzle encapsulation/ immobilisation system to produce uniform beads of alginate. J Biotechnol 1998; 63: 73-80.
29. Thu B, Gaserod O, Paus D, Mikkelsen A, Skjak-Braek G, Toffanin R, Vittur F, Rizzo R,. Inhomogeneous alginate gel spheres: An assessment of the polymer gradients by synchrotron radiation-induced x-ray emission, magnetic resonance microimaging, and mathematical modeling. Biopolymers 2000; 53: 60-71.
30. Quong D, Neufeld RJ, Skjak-Braek G, Poncelet D,. External versus internal source of calcium during the gelation of alginate beads for DNA encapsulation. Biotechnol Bioeng 1998; 57: 438-446.
31. Moe S, Skjak-Braek G, Smidsrod O, Ichijo H,. Calcium alginate gel fibers-Influence of alginate source and gel structure on fiber strength. J Appl Polym Sci 1994; 51: 1771-1775.
32. Thanos CG, Calafiore R, Basta G, Bintz BE, Bell WJ, Hudak J, Vasconcellos A, Schneider P, Skinner SJ, Geaney M, Tan P, Elliot RB, Tatnell M, Escobar L, Qian H, Mathiowitz E, Emerich DF,. Formulating the alginate-polyornithine biocapsule for prolonged stability: Evaluation of composition and manufacturing technique. J Biomed Mater Res A 2007; 83: 216-224.
33. Zhou D, Sun AM, Li X, Mamujee SN, Vacek I, Georgiou J, Wheeler MB,. In vitro and in vivo evaluation of insulin-producing beta TC6-F7 cells in microcapsules. Am J Physiol 1998; 274 (5 Pt 1): C1356-C1362.
34. D'Ambra R, Surana M, Efrat S, Starr RG, Fleischer N,. Regulation of insulin secretion from beta-cell lines derived from transgenic mice insulinomas resembles that of normal beta-cells. Endocrinology 1990; 126: 2815-2822.
35. Quellhorst E,. Insulin therapy during peritoneal dialysis: Pros and cons of various forms of administration. J Am Soc Nephrol 2002; 13 (Suppl 1): S92-S96.
36. de Vos P, Faas MM, Strand B, Calafiore R,. Alginate-based microcapsules for immunoisolation of pancreatic islets. Biomaterials 2006; 27: 5603-5617.
37. de Vos P, Smedema I, van Goor H, Moes H, van Zanten J, Netters S, de Leij LFM, de Haan A, de Haan BJ,. Association between macrophage activation and function of micro-encapsulated rat islets. Diabetologia 2003; 46: 666-673.
38. Fritschy WM, de Vos P, Groen H, Klatter FA, Pasma A, Wolters GH, van Schilfgaarde R,. The capsular overgrowth on microencapsulated pancreatic islet grafts in streptozotocin and autoimmune diabetic rats. Transplant Int 1994; 7: 264-271.
39. Menard M, Dusseault J, Langlois G, Baille WE, Tam SK, Yahia L, Zhu XX, Halle JP,. Role of protein contaminants in the immunogenicity of alginates. J Biomed Mater Res B Appl Biomater 2010; 93: 333-340.
40. Rokstad AM, Kulseng B, Strand BL, Skjak-Braek G, Espevik T,. Transplantation of alginate microcapsules with proliferating cells in mice: capsular overgrowth and survival of encapsulated cells of mice and human origin. Ann N Y Acad Sci 2001; 944: 216-225.
41. Stabler C, Wilks K, Sambanis A, Constantinidis I,. The effects of alginate composition on encapsulated betaTC3 cells. Biomaterials 2001; 22: 1301-1310.
42. de Vos P, DeHaan B, Pater J, VanSchilfgaarde R,. Association between capsule diameter, adequacy of encapsulation, and survival of microencapsulated rat islet allografts. Transplantation 1996; 62: 893-899.
43. Kulseng B, Skjak-Braek G, Ryan L, Andersson A, King A, Faxvaag A, Espevik T,. Transplantation of alginate microcapsules: Generation of antibodies against alginates and encapsulated porcine slet-like cell clusters. Transplantation 1999; 67: 978-984.
44. Lanza RP, Kuhtreiber WM, Ecker D, Staruk JE, Chick WL,. Xenotransplantation of porcine and bovine islets without immunosuppression using uncoated alginate microspheres. Transplantation 1995; 59: 1377-1384.